NCT03343873 The Effects of Different Anesthetics on Functional Connectivity
| NCT ID | NCT03343873 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Tiantan Hospital |
| Condition | Sedation |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2017-04-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2017-04-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is a prospective cohort study. The aim of the study is to determine different levels of sedative mechanism and the effect on brain functional connectivity of midazolam, dexmedetomidine and propofol.
Eligibility Criteria
Inclusion Criteria: * 1\. Male, 18 \~ 65 years old * 2\. Healthy Volunteer / Brain Tumor Patients * 3\. Senior high school and above * 4\. Sign informed consent Exclusion Criteria: * 1\. In vivo implant MRI check taboo * 2\. Cardiopulmonary liver and kidney and other systemic complications * 3\. History of major surgical anesthesia * 4\. Abuse of drugs, alcoholism history * 5\. Test drug allergy history * 6\. Claustrophobia * 7\. Left hand
Contact & Investigator
Ruquan Han, M.D., Ph.D
STUDY CHAIR
Department of Anesthesiology, Beijing Tiantan Hospital
Frequently Asked Questions
Who can join the NCT03343873 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 65 Years, studying Sedation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03343873 currently recruiting?
Yes, NCT03343873 is actively recruiting participants. Contact the research team at ruquan.han@gmail.com for enrollment information.
Where is the NCT03343873 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT03343873 clinical trial?
NCT03343873 is sponsored by Beijing Tiantan Hospital. The principal investigator is Ruquan Han, M.D., Ph.D at Department of Anesthesiology, Beijing Tiantan Hospital. The trial plans to enroll 240 participants.